Global Next Generation Sequencing Market

Next Generation Sequencing Market Size, Share, Growth Analysis, By Product & Service(NGS Consumables, Sequencing Services (Exome & Targeted Resequencing and Custom Panels, RNA Sequencing, DE NOVO Sequencing), By Technology(Sequencing By Synthesis, Ion Semiconductor Sequencing, Nanopore Sequencing, Single-molecule Real-time Sequencing), By Application(Diagnostics (Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Other Diagnostic Applications)), By End User(Academic Institutes And Research Centers, Pharmaceutical And Biotechnology Companies, Hospitals And Clinics, Reference Laboratories), By Region - Industry Forecast 2024-2031

Report ID: SQMIG35D2046 | Region: Global | Published Date: June, 2024
Pages: 157 | Tables: 98 | Figures: 76

Next Generation Sequencing Market News

  • In December 2023, marked the official release of TurBOT beta access with Oxford Nanopore collaborating with Tecan. The buyers are expected to receive the products by first quarter of the year 2024. The potential of the TurBOT is the availability of basecalling, data analysis, sample preparation as well as automated extraction of multiple samples in a single instrument. 

  • In December 2023, Illumina inked an MoU with African Society for Laboratory Medicine with the aims of deploy genomics in the region of Africa to combat infectious diseases. 

  • In April 2024, in LAUSANNE, Switzerland NewBiologix technology innovation company, focused on addressing the issues in gene therapy production, has released its new platform for NGS and optical mapping. This integrated set of services is expected to offer the biopharmaceutical industry a convenient and efficient solution for genomic analyses.

Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.



Global Next Generation Sequencing Market size was valued at USD 7.82 Billion in 2022 and is poised to grow from USD 9.27 Billion in 2023 to USD 36.04 Billion by 2031, growing at a CAGR of 18.5% in the forecast period (2024-2031). 

The market is fragmented in nature. The prominent players operating in the market are always adopting various growth strategies to stay afloat in the market. Product launches, innovations, mergers & acquisitions, collaborations and partnerships, and intensive R&D are some of the growth strategies that are adopted by these key players to thrive in the competitive market. The key market players are also constantly focused on R&D to supply industries with the most efficient and cost-effective solutions. 'Illumina Inc. (US) ', 'Thermo Fisher Scientific, Inc. (US) ', 'PerkinElmer Inc. (US) ', 'BGI Group (China) ', 'Agilent Technologies Inc. (US) ', 'Eurofins Scientific SE (Luxembourg) ', 'Pacific Biosciences of California Inc. (US) ', 'Oxford Nanopore Technologies (UK) ', 'QIAGEN NV (Netherlands) ', 'F. Hoffmann-La Roche AG (Switzerland) ', 'GENEWIZ Inc. (US) ', 'Psomagen, Inc. (South Korea) ', '10x Genomics Inc. (US) ', 'Takara Bio (Japan) ', 'Zymo Research (US) ', 'NuGen Technologies (US) ', 'Hamilton Company (US) ', 'Beckman Coulter (US) ', 'Becton, Dickinson, and Company (US) ', 'Lucigen Corporation (US) ', 'Novogene Co., Ltd. (China)'

Developing new and innovative technologies has seen the emergence of NGS that is faster, movable and easy to use. Such advancement would facilitate faster and accurate analysis, including substantially shorter turnaround time. Thus, gaining such technological advancements offer competitive advantage to firms, enhance high-rate investment in research and innovation, and consequently boost the market. 

Expanding Applications and Advancements in NGS Technology: It was witnessed that high and low throughput research uses NGS and going to high because of more simplicity, continuously dropping prices and strengthening of bioinformatics services. The use of NGS-based testing system is gradually expanding toward different clinical fields, such as oncology, reproductive health, and genetics. Companies and organizations do not relent; they seek improvement and advancement, like in the case of the RNA-sequencing, which seeks to cover a wide range of scientific and clinical areas. 

North America is anticipated to dominate this market in 2023 with its highest market share among other regions. The main driving force for the regional market is the presence of various next generation sequencing players and clinical laboratories that utilize next generation sequencing to perform genetic testing in the region. Apart from this, the introduction of new products by key players and technological improvements in the currently available products will also benefit the regional industry in the forecast period. 

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.


Feedback From Our Clients

Global Next Generation Sequencing Market

Report ID: SQMIG35D2046